Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEET (Unaudited)

v3.21.1
CONDENSED BALANCE SHEET (Unaudited) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 640,630
Prepaid expenses 774,350
Deferred offering costs 165,778
Due from Sponsor 395,000
Total Current Assets 1,809,980 165,778
Cash and marketable securities held in Trust Account 253,016,975
Total Assets 254,826,955 165,778
Current liabilities    
Accrued expenses 168,060
Accrued offering costs 335,700 140,778
Promissory note - related party 5,000
Total Current Liabilities 503,760 145,778
Warrant Liabilities 31,472,230
Deferred underwriting fee payable 8,855,000
Total Liabilities 40,830,990 145,778
Commitments
Class A ordinary shares subject to possible redemption, 20,898,193, shares at redemption value 208,995,955
Shareholders' Equity    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 6,884,518 24,367
Accumulated deficit (1,885,581) (5,000)
Total Shareholders' Equity 5,000,010 20,000
Total Liabilities and Shareholders' Equity 254,826,955 165,778
Class A ordinary Shares [Member]    
Shareholders' Equity    
Ordinary shares 440
Class B ordinary Shares [Member]    
Shareholders' Equity    
Ordinary shares $ 633 $ 633